# Clindamycin

NDC: 25021-115
Generic name: Clindamycin Phosphate
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20120515

FDA application: ANDA090108

## Active ingredients

- CLINDAMYCIN PHOSPHATE: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-115"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-115
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a6967b3-5563-4bed-9eee-d400f800e799
